BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hass HG, Smith U, Jäger C, Schäffer M, Wellhäuber U, Hehr T, Markmann HU, Nehls O, Denzlinger C. Signet ring cell carcinoma of the stomach is significantly associated with poor prognosis and diffuse gastric cancer (Lauren’s): single-center experience of 160 cases. Onkologie. 2011;34:682-686. [PMID: 22156447 DOI: 10.1159/000334545] [Cited by in Crossref: 35] [Cited by in F6Publishing: 39] [Article Influence: 3.2] [Reference Citation Analysis]
Number Citing Articles
1 Thompson RJ, Ranaghan L, Kennedy R, Clements W, Carey PD, Kennedy JA. Survival following operative management of gastric linitis plastica compared with non-operative management. Ann R Coll Surg Engl 2017;99:228-32. [PMID: 27809576 DOI: 10.1308/rcsann.2016.0337] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
2 Nadauld LD, Garcia S, Natsoulis G, Bell JM, Miotke L, Hopmans ES, Xu H, Pai RK, Palm C, Regan JF, Chen H, Flaherty P, Ootani A, Zhang NR, Ford JM, Kuo CJ, Ji HP. Metastatic tumor evolution and organoid modeling implicate TGFBR2 as a cancer driver in diffuse gastric cancer. Genome Biol 2014;15:428. [PMID: 25315765 DOI: 10.1186/s13059-014-0428-9] [Cited by in Crossref: 78] [Cited by in F6Publishing: 68] [Article Influence: 9.8] [Reference Citation Analysis]
3 Zhu YT, Chen XZ, Chen Y, Zhou YW, Tang LS, Luo DY, Li Q, Qiu M, Wang X, Cao D, Yang Y, Shen YL, Li ZP, Bi F, Liu JY, Gou HF. Chemoradiotherapy Is Inferior to Chemotherapy Alone in Adjuvant Setting for Signet Ring Cell Containing Gastric Cancer. Front Oncol 2020;10:570268. [PMID: 33324548 DOI: 10.3389/fonc.2020.570268] [Reference Citation Analysis]
4 Li D, Zhang J, Xi Y, Zhang L, Li W, Cui J, Xing R, Pan Y, Pan Z, Li F, Lu Y. Mitogen-activated protein kinase activator with WD40 repeats (MAWD) and MAWD-binding protein induce cell differentiation in gastric cancer. BMC Cancer 2015;15:637. [PMID: 26373288 DOI: 10.1186/s12885-015-1637-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
5 Yin X, Fang T, Wang Y, Wang Y, Zhang D, Li C, Xue Y. Prognostic significance of serum inflammation indexes in different Lauren classification of gastric cancer. Cancer Med 2021;10:1103-19. [PMID: 33410261 DOI: 10.1002/cam4.3706] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Nie RC, Yuan SQ, Li YF, Chen YM, Chen XJ, Zhu BY, Xu LP, Zhou ZW, Chen S, Chen YB. Clinicopathological Characteristics and Prognostic Value of Signet Ring Cells in Gastric Carcinoma: A Meta-Analysis. J Cancer 2017;8:3396-404. [PMID: 29151922 DOI: 10.7150/jca.21017] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
7 Voron T, Messager M, Duhamel A, Lefevre J, Mabrut JY, Goere D, Meunier B, Brigand C, Hamy A, Glehen O, Mariette C, Paye F. Is signet-ring cell carcinoma a specific entity among gastric cancers? Gastric Cancer. 2016;19:1027-1040. [PMID: 26606931 DOI: 10.1007/s10120-015-0564-2] [Cited by in Crossref: 25] [Cited by in F6Publishing: 35] [Article Influence: 3.6] [Reference Citation Analysis]
8 Li Y, Xie D, Chen X, Hu T, Lu S, Han Y. Prognostic Value of the Site of Distant Metastasis and Surgical Interventions in Metastatic Gastric Cancer: A Population-Based Study. Technol Cancer Res Treat 2020;19:1533033820964131. [PMID: 33111644 DOI: 10.1177/1533033820964131] [Reference Citation Analysis]
9 Liu X, Xu D, Huang C, Guo Y, Wang S, Zhu C, Xu J, Zhang Z, Shen Y, Zhao W, Zhao G. Regulatory T cells and M2 macrophages present diverse prognostic value in gastric cancer patients with different clinicopathologic characteristics and chemotherapy strategies. J Transl Med. 2019;17:192. [PMID: 31174544 DOI: 10.1186/s12967-019-1929-9] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 5.3] [Reference Citation Analysis]
10 Yue G, Sun X, Gimenez-Capitan A, Shen J, Yu L, Teixido C, Guan W, Rosell R, Liu B, Wei J. TAZ is highly expressed in gastric signet ring cell carcinoma. Biomed Res Int 2014;2014:393064. [PMID: 24707483 DOI: 10.1155/2014/393064] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
11 Machlowska J, Pucułek M, Sitarz M, Terlecki P, Maciejewski R, Sitarz R. State of the art for gastric signet ring cell carcinoma: from classification, prognosis, and genomic characteristics to specified treatments. Cancer Manag Res 2019;11:2151-61. [PMID: 30936747 DOI: 10.2147/CMAR.S188622] [Cited by in Crossref: 19] [Cited by in F6Publishing: 12] [Article Influence: 6.3] [Reference Citation Analysis]
12 Ren J, Niu G, Wang X, Song T, Hu Z, Ke C. Effect of Age on Prognosis of Gastric Signet-Ring Cell Carcinoma: A SEER Database Analysis. Med Sci Monit. 2018;24:8524-8532. [PMID: 30473583 DOI: 10.12659/msm.911766] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
13 Berlth F, Bollschweiler E, Drebber U, Hoelscher AH, Moenig S. Pathohistological classification systems in gastric cancer: Diagnostic relevance and prognostic value. World J Gastroenterol 2014; 20(19): 5679-5684 [PMID: 24914328 DOI: 10.3748/wjg.v20.i19.5679] [Cited by in CrossRef: 71] [Cited by in F6Publishing: 64] [Article Influence: 8.9] [Reference Citation Analysis]
14 Yin X, Fang T, Wang Y, Li C, Wang Y, Zhang D, Xue Y. Efficacy of Postoperative FOLFOX Versus XELOX Chemotherapy for Gastric Cancer and Prognostic Value of Platelet-Lymphocyte Ratio in Patients Receiving XELOX. Front Oncol 2020;10:584772. [PMID: 33425738 DOI: 10.3389/fonc.2020.584772] [Reference Citation Analysis]
15 Li DM, Zhang J, Li WM, Cui JT, Pan YM, Liu SQ, Xing R, Lu YY. MAWBP and MAWD inhibit proliferation and invasion in gastric cancer. World J Gastroenterol 2013; 19(18): 2781-2792 [PMID: 23687415 DOI: 10.3748/wjg.v19.i18.2781] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
16 Lim B, Kim HJ, Heo H, Huh N, Baek SJ, Kim JH, Bae DH, Seo EH, Lee SI, Song KS, Kim SY, Kim YS, Kim M. Epigenetic silencing of miR-1271 enhances MEK1 and TEAD4 expression in gastric cancer. Cancer Med 2018. [PMID: 29862663 DOI: 10.1002/cam4.1605] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
17 Ock CY, Nam AR, Bang JH, Kim TY, Lee KH, Han SW, Im SA, Kim TY, Bang YJ, Oh DY. Signature of cytokines and angiogenic factors (CAFs) defines a clinically distinct subgroup of gastric cancer. Gastric Cancer. 2015; Epub ahead of print. [PMID: 26681196 DOI: 10.1007/s10120-015-0583-z] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
18 Schirren R, Novotny A, Oesterlin C, Slotta-Huspenina J, Friess H, Reim D. Significance of Lauren Classification in Patients Undergoing Neoadjuvant/Perioperative Chemotherapy for Locally Advanced Gastric or Gastroesophageal Junction Cancers-Analysis from a Large Single Center Cohort in Germany. Cancers (Basel) 2021;13:290. [PMID: 33466779 DOI: 10.3390/cancers13020290] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Abrams B, Wavreille VA, Husbands BD, Matz BM, Massari F, Liptak JM, Cray MT, de Mello Souza CH, Wustefeld-Janssens BG, Oblak ML, Su L, Selmic LE. Perioperative complications and outcome after surgery for treatment of gastric carcinoma in dogs: A Veterinary Society of Surgical Oncology retrospective study of 40 cases (2004-2018). Vet Surg 2019;48:923-32. [PMID: 31140634 DOI: 10.1111/vsu.13239] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
20 Lu M, Yang Z, Feng Q, Yu M, Zhang Y, Mao C, Shen L, Tang J. The characteristics and prognostic value of signet ring cell histology in gastric cancer: A retrospective cohort study of 2199 consecutive patients. Medicine (Baltimore) 2016;95:e4052. [PMID: 27399088 DOI: 10.1097/MD.0000000000004052] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 4.0] [Reference Citation Analysis]
21 Wei J, Yao T, Wang Y, Li L, Pan C, Zhang N. Prognostic analysis of stage III gastric cancer after curative surgery according to the newest TNM classification. Clin Transl Oncol 2019;21:232-8. [PMID: 29968135 DOI: 10.1007/s12094-018-1913-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
22 Kim BS, Oh ST, Yook JH, Kim BS. Signet ring cell type and other histologic types: differing clinical course and prognosis in T1 gastric cancer. Surgery. 2014;155:1030-1035. [PMID: 24792508 DOI: 10.1016/j.surg.2013.08.016] [Cited by in Crossref: 39] [Cited by in F6Publishing: 44] [Article Influence: 4.9] [Reference Citation Analysis]
23 Schirren R, Novotny A, Friess H, Reim D. Histopathologic Response Is a Positive Predictor of Overall Survival in Patients Undergoing Neoadjuvant/Perioperative Chemotherapy for Locally Advanced Gastric or Gastroesophageal Junction Cancers-Analysis from a Large Single Center Cohort in Germany. Cancers (Basel) 2020;12:E2244. [PMID: 32796715 DOI: 10.3390/cancers12082244] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
24 Schildberg C, Abbas M, Merkel S, Agaimy A, Dimmler A, Schlabrakowski A, Croner R, Leupolt J, Hohenberger W, Allgayer H. COX-2, TFF1, and Src define better prognosis in young patients with gastric cancer. J Surg Oncol. 2013;108:409-413. [PMID: 24037722 DOI: 10.1002/jso.23416] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
25 Zheng Z, Jin X, He Q, Lin B, Su H, Chen H, Fei S, Fei Z, Chen G, Pan H, Chen X, Xie C. The Efficacy of Taxanes- and Oxaliplatin-Based Chemotherapy in the Treatment of Gastric Cancer After D2 Gastrectomy for Different Lauren Types. Medicine (Baltimore) 2016;95:e2785. [PMID: 26871834 DOI: 10.1097/MD.0000000000002785] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
26 Zhang SX, Liu W, Ai B, Sun LL, Chen ZS, Lin LZ. Current Advances and Outlook in Gastric Cancer Chemoresistance: A Review. Recent Pat Anticancer Drug Discov 2021. [PMID: 34587888 DOI: 10.2174/1574892816666210929165729] [Reference Citation Analysis]
27 Wei SH, Li W, Liu Y, Gao DK, Pan J, Gu CW, Wu HR. Disturbance of autophagy-lysosome signaling molecule expression in human gastric adenocarcinoma. Oncol Lett 2014;7:635-40. [PMID: 24527069 DOI: 10.3892/ol.2013.1773] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
28 Efared B, Kadi M, Tahiri L, Lahmidani N, Hassani KM, Bouhaddouti HE, Benbrahim Z, Adil IS, Chbani L. Gastric Signet Ring Cell Carcinoma: A Comparative Analysis of Clinicopathologic Features. Cancer Control 2020;27:1073274820976596. [PMID: 33269609 DOI: 10.1177/1073274820976596] [Reference Citation Analysis]
29 Hugen S, Thomas RE, German AJ, Burgener IA, Mandigers PJJ. Gastric carcinoma in canines and humans, a review. Vet Comp Oncol 2017;15:692-705. [PMID: 27549077 DOI: 10.1111/vco.12249] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
30 Chen J, Cai R, Ren G, Zhao J, Li H, Guo C, He W, Wu X, Zhang W. Differences in clinicopathological characteristics and computed tomography findings between signet ring cell carcinoma and nonsignet ring cell carcinoma in early and advanced gastric cancer. Cancer Med 2018;7:1160-9. [PMID: 29533002 DOI: 10.1002/cam4.1417] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
31 Chen G, Jiao ZY. Challenge and thought on treatment of diffuse gastric cancer. Shijie Huaren Xiaohua Zazhi 2016; 24(17): 2608-2616 [DOI: 10.11569/wcjd.v24.i17.2608] [Reference Citation Analysis]
32 Chen CL, Xue DX, Chen HH, Liang MZ, Lin DZ, Yu M, Chen JX, Wu WL. Nomograms to Predict Overall and Cancer-Specific Survival in Gastric Signet-Ring Cell Carcinoma. J Surg Res 2021;266:13-26. [PMID: 33979736 DOI: 10.1016/j.jss.2021.03.053] [Reference Citation Analysis]
33 Cheng X, Yu S, Wang Y, Cui Y, Li W, Yu Y, Tang C, Jiang H, Ji Y, Sun Y, Wang X, Shen Z, Liu F, Liu TS. The role of oxaliplatin in the adjuvant setting of different Lauren's type of gastric adenocarcinoma after D2 gastrectomy: a real-world study. Gastric Cancer 2019;22:587-97. [PMID: 30426294 DOI: 10.1007/s10120-018-0895-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
34 Wei F, Lyu H, Wang S, Chu Y, Chen F. Postoperative Radiotherapy Improves Survival in Gastric Signet-Ring Cell Carcinoma: a SEER Database Analysis. J Gastric Cancer 2019;19:393-407. [PMID: 31897342 DOI: 10.5230/jgc.2019.19.e36] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
35 Stiekema J, Cats A, Kuijpers A, van Coevorden F, Boot H, Jansen EP, Verheij M, Balague Ponz O, Hauptmann M, van Sandick JW. Surgical treatment results of intestinal and diffuse type gastric cancer. Implications for a differentiated therapeutic approach? Eur J Surg Oncol. 2013;39:686-693. [PMID: 23498364 DOI: 10.1016/j.ejso.2013.02.026] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 2.3] [Reference Citation Analysis]
36 Lee DH, Kim SH, Joo I, Han JK. CT Perfusion evaluation of gastric cancer: correlation with histologic type. Eur Radiol 2018;28:487-95. [PMID: 28779403 DOI: 10.1007/s00330-017-4979-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
37 Enlow JM, Denlinger CE, Stroud MR, Ralston JS, Reed CE. Adenocarcinoma of the esophagus with signet ring cell features portends a poor prognosis. Ann Thorac Surg. 2013;96:1927-1932. [PMID: 23987898 DOI: 10.1016/j.athoracsur.2013.06.047] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 2.1] [Reference Citation Analysis]
38 Hsieh MC, Wang SH, Wei CT, Chen CY, Chen YY, Pei SN, Tsai YF, Rau KM. S1 versus Doublet Regimens as Adjuvant Chemotherapy in Patients with Advanced Gastric Cancer after Radical Surgery with D2 Dissection-A Propensity Score Matching Analysis. Cancers (Basel) 2020;12:E2384. [PMID: 32842507 DOI: 10.3390/cancers12092384] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
39 Futtrup TB, Hasselby JP, Baeksgaard L. Gastric signet ring cell carcinoma presenting as diffuse, infiltrating myositis--a case report and review of the literature. J Gastrointest Cancer 2014;45 Suppl 1:62-5. [PMID: 23996197 DOI: 10.1007/s12029-013-9547-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
40 Chen L, Shi Y, Yuan J, Wu Q, Han Y, Qin R, Jia B, Wei B, Wei L, Dai G, Jiao S. Evaluation of docetaxel- and oxaliplatin-based adjuvant chemotherapy in postgastrectomy gastric cancer patients reveals obvious survival benefits in docetaxel-treated mixed signet ring cell carcinoma patients. Med Oncol. 2014;31:159. [PMID: 25119501 DOI: 10.1007/s12032-014-0159-5] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]